HUA MEDICINE-B (02552.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Nov24

Huameng Medicine Experiences Rapid Sales Growth Post Commercialization Takeover and Pushes Development of Second-Generation GKA

03:45

Sep19

Huamedx-B Sees Significant Revenue Growth in H1 2025, Aims for Over 1 Billion Yuan in 2027

08:47

Aug28

HUA MEDICINE-B released FY2025 Q1 earnings on August 28 (BJT), actual revenue HKD 116.43 M, actual EPS HKD 0.6372

15:00

Hu Lun Pharmaceutical Reports Turnaround in Mid-Year Earnings After Bayer Agreement Termination

08:57

HUA MEDICINE-B released FY2025 Q2 earnings on August 28 Pre-Market (BJT), actual revenue HKD 118.99 M, actual EPS HKD 0.6512

01:00

HUA MEDICINE-B released FY2025 Semi-Annual Earnings on August 28 Pre-Market (BJT), actual revenue HKD 235.42 M, actual EPS HKD 1.2884

01:00

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 118.99 M, Net Income 647.93 M, EPS 0.6512

Mar27

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 81.51 M, Net Income -57.4 M, EPS -0.0584

Aug29

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 55.16 M, Net Income -76.42 M, EPS -0.0805

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More